Niagen Bioscience divests hromaDex Reference Standards business to LGC

Niagen Bioscience (NAGE) announced the sale of its ChromaDex Reference Standards business to LGC, as of February 24, in an all-cash transaction. The company said, “The divestiture further streamlines Niagen Bioscience’s operations, advances the Company’s strategy to exit non-core activities, and focuses resources on NAD+ science, intellectual property, and commercial growth within the longevity industry.”